Research shows that commonly-cited equivalence and technical concerns around BYOD may not deter adoption
There are two main areas of concern in using a BYOD approach for PRO data collection in clinical studies. The first relates to equivalence and how different device sizes and operating systems might affect the measurement properties of a PRO instrument. The second relates to the technical and practical aspects of using a patient's own device, including data capacity, upgrades to operating systems and a change of device mid-study, which could negatively impact PRO data collection.
ICON's research, completed in association with
The survey results found that biopharma and CRO professionals appear to be significantly less deterred by challenges of equivalence and the practical and technical challenges associated with BYOD in clinical studies. Survey highlights include:
- Only 44% of respondents thought that equivalence should be demonstrated on all possible devices used in a BYOD study.
- The majority of respondents agreed that demonstration of equivalence on a single device specification was acceptable as long devices with smaller screen sizes or screen resolutions could be prevented. Only 30% of respondents disagreed with this approach.
- Over 75% responded that they were "not at all concerned" or only "a little concerned" about issues such as a PRO app being deleted, inadequate storage space for PRO data, or the trial participant becoming distracted by other apps on their device during PRO completion.
- Over half (53%) were not concerned that people may be able to turn off notifications, such as diary reminders, and 74% were not worried about trial participants changing their phones mid-study.
"As a CRO that is at the forefront of innovating the clinical trial
process, we wanted to research industry perceptions towards BYOD, an
approach that has the potential to greatly enhance patient engagement
and compliance," commented
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and industry
conditions. These statements are not guarantees of future performance or
actual results, and actual results, developments and business decisions
may differ from those stated in this press release. The forward-looking
statements are subject to future events, risks, uncertainties and other
factors that could cause actual results to differ materially from those
projected in the statements, including, but not limited to, the ability
to enter into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the integration of
new business mergers and acquisitions, as well as economic and global
market conditions and other risks and uncertainties detailed from time
to time in
Cami Frederix, +44 (0) 207 067 0272
News Provided by Acquire Media